Packaging demand rises; Generics recall in U.K.;

> World pharmaceutical packaging demand is projected to increase 6.3 percent annually to $62.3 billion in 2013. Article

> Eight pharma companies were forced to recall generics in the U.K. last week after regulators found "serious" deficiencies in manufacturing practices at a single contract manufacturer in India. Report

> Abbott Laboratories has named Olivier Bohuon executive vice president for pharmaceutical products. Bohuon succeeds James Tyree, who will move to a new role as president of Abbott Biotech Ventures Inc., a unit that invests in early-stage pharmaceuticals and biologics. Announcement

> Some 350 Caraco Pharmaceutical workers will bear the brunt of a much-publicized production stoppage following the FDA seizure of 33 medications and drug ingredients. Report

> Xianyang, China-based Biostar Pharmaceuticals, a manufacturer of pharmaceutical products and medical nutrients, has begun implementation of a rural cooperative drug supply network plan. Release

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.